| pubmed-article:20646649 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20646649 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:20646649 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:20646649 | lifeskim:mentions | umls-concept:C0278554 | lld:lifeskim |
| pubmed-article:20646649 | lifeskim:mentions | umls-concept:C0302523 | lld:lifeskim |
| pubmed-article:20646649 | lifeskim:mentions | umls-concept:C0700325 | lld:lifeskim |
| pubmed-article:20646649 | lifeskim:mentions | umls-concept:C0671970 | lld:lifeskim |
| pubmed-article:20646649 | lifeskim:mentions | umls-concept:C1512552 | lld:lifeskim |
| pubmed-article:20646649 | lifeskim:mentions | umls-concept:C0205420 | lld:lifeskim |
| pubmed-article:20646649 | pubmed:issue | 14 | lld:pubmed |
| pubmed-article:20646649 | pubmed:dateCreated | 2010-7-21 | lld:pubmed |
| pubmed-article:20646649 | pubmed:abstractText | To evaluate the efficacy of accelerated hyperfractionation (CAF) radiotherapy plus concurrent capecitabine in the treatment of locoregional recurrent rectal cancer. | lld:pubmed |
| pubmed-article:20646649 | pubmed:language | chi | lld:pubmed |
| pubmed-article:20646649 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20646649 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20646649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20646649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20646649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20646649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20646649 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20646649 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:20646649 | pubmed:issn | 0376-2491 | lld:pubmed |
| pubmed-article:20646649 | pubmed:author | pubmed-author:DaiYongY | lld:pubmed |
| pubmed-article:20646649 | pubmed:author | pubmed-author:YuJin-mingJM | lld:pubmed |
| pubmed-article:20646649 | pubmed:author | pubmed-author:ZhangJian-don... | lld:pubmed |
| pubmed-article:20646649 | pubmed:author | pubmed-author:ShaoZhen-yuZY | lld:pubmed |
| pubmed-article:20646649 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20646649 | pubmed:day | 13 | lld:pubmed |
| pubmed-article:20646649 | pubmed:volume | 90 | lld:pubmed |
| pubmed-article:20646649 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20646649 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20646649 | pubmed:pagination | 982-4 | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:meshHeading | pubmed-meshheading:20646649... | lld:pubmed |
| pubmed-article:20646649 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20646649 | pubmed:articleTitle | [Efficacy observation of accelerated hyperfractionation recourse radiotherapy plus concurrent capecitabine in the treatment of locoregional recurrent rectal cancer]. | lld:pubmed |
| pubmed-article:20646649 | pubmed:affiliation | Department of Radiation Oncology, Qianfoshan Hospital, Shandong University, Jinan 250014, China. | lld:pubmed |
| pubmed-article:20646649 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20646649 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:20646649 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20646649 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
